Enanta Pharmaceuticals (ENTA) Cash from Investing Activities (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.25% |
| Dec 31, 2025 | -2,160.02% |
| Sep 30, 2025 | 108.67% |
| Jun 30, 2025 | -506.16% |
| Mar 31, 2025 | -106.34% |
| Dec 31, 2024 | 261.26% |
| Sep 30, 2024 | 400.60% |
| Jun 30, 2024 | -110.82% |
| Mar 31, 2024 | 546.93% |
| Dec 31, 2023 | -210.82% |
| Sep 30, 2023 | 108.12% |
| Jun 30, 2023 | -411.66% |
| Mar 31, 2023 | 39.31% |
| Dec 31, 2022 | 18.91% |
| Sep 30, 2022 | 74.05% |
| Jun 30, 2022 | 146.27% |
| Mar 31, 2022 | -177.04% |
| Dec 31, 2021 | -37.40% |
| Sep 30, 2021 | 266.30% |
| Jun 30, 2021 | -271.67% |
| Mar 31, 2021 | 245.93% |
| Dec 31, 2020 | -796.69% |
| Sep 30, 2020 | -90.65% |
| Jun 30, 2020 | -3.49% |
| Mar 31, 2020 | 174.59% |
| Dec 31, 2019 | 28.74% |
| Sep 30, 2019 | -251.64% |
| Jun 30, 2019 | -1,223.07% |
| Mar 31, 2019 | 106.32% |
| Dec 31, 2018 | -163.32% |
| Sep 30, 2018 | 74.73% |
| Jun 30, 2018 | -587.25% |
| Mar 31, 2018 | 363.77% |
| Dec 31, 2017 | 83.57% |
| Sep 30, 2017 | -294.58% |
| Jun 30, 2017 | 324.03% |
| Mar 31, 2017 | 108.79% |
| Dec 31, 2016 | 114.07% |
| Sep 30, 2016 | 80.44% |
| Jun 30, 2016 | -6,776.81% |
| Mar 31, 2016 | 91.89% |
| Dec 31, 2015 | -237.43% |
| Sep 30, 2015 | -49.87% |
| Jun 30, 2015 | 107.60% |
| Mar 31, 2015 | -1,629.60% |
| Dec 31, 2014 | -23.73% |
| Sep 30, 2014 | 133.73% |
| Jun 30, 2014 | -258.35% |
| Mar 31, 2014 | 1,178.58% |
| Dec 31, 2013 | 117.66% |
| Sep 30, 2013 | 84.16% |
| Jun 30, 2013 | -204.07% |
| Mar 31, 2013 | -734.57% |
| Dec 31, 2012 | -72.96% |
| Sep 30, 2012 | 171.72% |